Grifols S.A. (NASDAQ:GRFS) went down by -0.13% from its latest closing price compared to the recent 1-year high of $20.49. The company’s stock price has collected -3.47% of loss in the last five trading sessions. Press Release reported on 06/01/21 that Grifols introduces HyperHEP B(R) (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
Is It Worth Investing in Grifols S.A. (NASDAQ :GRFS) Right Now?
Grifols S.A. (NASDAQ:GRFS) scored a price-to-earnings ratio above its average ratio, recording 31.29 x from its present earnings ratio. Opinions of the stock are interesting as 1 analysts out of 2 who provided ratings for Grifols S.A. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $26.47. Today, the average trading volume of GRFS was 587.37K shares.
GRFS’s Market Performance
GRFS stocks went down by -3.47% for the week, with a monthly drop of -15.00% and a quarterly performance of -15.61%, while its annual performance rate touched -22.18%. The volatility ratio for the week stands at 1.57% while the volatility levels for the past 30 days are set at 1.94% for Grifols S.A.. The simple moving average for the period of the last 20 days is -8.77% for GRFS stocks with a simple moving average of -14.15% for the last 200 days.
GRFS Trading at -12.86% from the 50-Day Moving Average
After a stumble in the market that brought GRFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.33% of loss for the given period.
Volatility was left at 1.94%, however, over the last 30 days, the volatility rate increased by 1.57%, as shares sank -12.92% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.74% lower at present.
During the last 5 trading sessions, GRFS fell by -3.47%, which changed the moving average for the period of 200-days by -10.37% in comparison to the 20-day moving average, which settled at $16.66. In addition, Grifols S.A. saw -17.03% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GRFS
Current profitability levels for the company are sitting at:
- +18.26 for the present operating margin
- +39.92 for the gross margin
The net margin for Grifols S.A. stands at +11.58. The total capital return value is set at 7.07, while invested capital returns managed to touch 5.31.
Based on Grifols S.A. (GRFS), the company’s capital structure generated 135.30 points at debt to equity in total, while total debt to capital is 57.50. Total debt to assets is 45.25, with long-term debt to equity ratio resting at 129.04. Finally, the long-term debt to capital ratio is 54.84.
When we switch over and look at the enterprise to sales, we see a ratio of 4.55, with the company’s debt to enterprise value settled at 0.28. The receivables turnover for the company is 10.96 and the total asset turnover is 0.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.37.